Anjana Talwar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Anjana Talwar has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
Geetanjali Bade
10 shared publicationsRandeep Guleria
6 shared publicationsMeghashree Sampath
5 shared publications- Geetanjali Bade
Department of Physiology, All India Institute of Medical Sciences, New Delhi, India
4 shared publications Karan Madan
All India Institute of Medical Sciences, New Dehi, India
4 shared publicationsAnant Mohan
2 shared publications
Latest Publications
- 2 September 2026
- Published by Elsevier in Respiratory Medicine
- Vol. 263
Impulse oscillometry reveals subclinical exercise-induced bronchoconstriction undetected by spirometry in healthy young adult males
- 2 September 2026
- Published by Elsevier in Respiratory Medicine
- Vol. 263
Impulse oscillometry reveals subclinical exercise-induced bronchoconstriction undetected by spirometry in healthy young adult males
- Open Access
- 24 October 2025
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 26 (6) , 333-339
Effect of Ambient Air Pollutants on Acute changes in Pulmonary Variables and Inflammatory Markers in Healthy Adults: A Pilot Study
Effect of Ambient Air Pollutants on Acute changes in Pulmonary Variables and Inflammatory Markers in Healthy Adults: A Pilot Study - Thoracic Research and Practice
- 24 October 2025
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 26 (6) , 333-339
Open AccessEffect of Ambient Air Pollutants on Acute changes in Pulmonary Variables and Inflammatory Markers in Healthy Adults: A Pilot Study
Effect of Ambient Air Pollutants on Acute changes in Pulmonary Variables and Inflammatory Markers in Healthy Adults: A Pilot Study - Thoracic Research and Practice
- Open Access
- 1 January 2025
- Published by Wiley in Pulmonary Medicine
- Vol. 2025 (1)
Role of Regulatory T Cells in Chronic Obstructive Pulmonary Disease
Background: Chronic obstructive pulmonary disease (COPD) is a progressive lung disorder characterized by poorly reversible airway obstruction. COPD being an inflammatory disorder has been proposed to have an imbalance between proinflammatory and anti‐inflammatory factors. Regulatory T cells (Tregs) being a negative regulator of immune response have been observed to play an important role in other inflammatory diseases as well as animal models of inflammation. Objective : This study is aimed at assessing the suppressive functions of circulatory Tregs and examining the inductive capacity of naive CD4+ T cells to generate induced Tregs. Methods: The study was conducted in 20 COPD patients (smokers n = 10; reformed smokers n = 10) and 20 age‐matched healthy controls (smokers n = 10; nonsmokers n = 10). Peripheral blood mononuclear cells were isolated from blood using Ficoll density gradient separation. The suppressive functions were evaluated by assessing the proliferation of T responder cells (CD4+CD25−) in the presence of circulatory Tregs (CD4+CD25+) under polyclonal stimulation. In addition, cytokine‐mediated suppression was assessed in the culture supernatants of the suppression assay. Inductive capacity was assessed by stimulating naive CD4+ T cells to generate iTregs in the presence of anti‐CD3, IL‐2, and TGF‐ β 1. Results: The percent suppression of T responder cells by Tregs was significantly lower in COPD smokers ( p = 0.03) and COPD reformed smokers ( p = 0.04) as compared to control smokers. On the assessment of cytokine‐mediated suppression, significantly reduced IL‐2 in COPD S as compared to COPD RS ( p < 0.05) and reduced IL‐10 and TGFß1 in COPD S as compared to CNS ( p < 0.05) and CS ( p < 0.05) was observed in the culture supernatants of suppression assay. In addition, a significantly higher frequency of iTregs with phenotype CD4+CD25+CD45RA+CD127− was observed in COPD S as compared to COPD RS ( p < 0.01). Discussion: Characteristics changes were observed in patients with COPD. The compromised Tregs function, despite the increase in systemic inflammation, suggests a potential role of these cells in the pathogenesis of the disease.
- 1 January 2025
- Published by Wiley in Pulmonary Medicine
- Vol. 2025 (1)
Open AccessRole of Regulatory T Cells in Chronic Obstructive Pulmonary Disease
Background: Chronic obstructive pulmonary disease (COPD) is a progressive lung disorder characterized by poorly reversible airway obstruction. COPD being an inflammatory disorder has been proposed to have an imbalance between proinflammatory and anti‐inflammatory factors. Regulatory T cells (Tregs) being a negative regulator of immune response have been observed to play an important role in other inflammatory diseases as well as animal models of inflammation. Objective : This study is aimed at assessing the suppressive functions of circulatory Tregs and examining the inductive capacity of naive CD4+ T cells to generate induced Tregs. Methods: The study was conducted in 20 COPD patients (smokers n = 10; reformed smokers n = 10) and 20 age‐matched healthy controls (smokers n = 10; nonsmokers n = 10). Peripheral blood mononuclear cells were isolated from blood using Ficoll density gradient separation. The suppressive functions were evaluated by assessing the proliferation of T responder cells (CD4+CD25−) in the presence of circulatory Tregs (CD4+CD25+) under polyclonal stimulation. In addition, cytokine‐mediated suppression was assessed in the culture supernatants of the suppression assay. Inductive capacity was assessed by stimulating naive CD4+ T cells to generate iTregs in the presence of anti‐CD3, IL‐2, and TGF‐ β 1. Results: The percent suppression of T responder cells by Tregs was significantly lower in COPD smokers ( p = 0.03) and COPD reformed smokers ( p = 0.04) as compared to control smokers. On the assessment of cytokine‐mediated suppression, significantly reduced IL‐2 in COPD S as compared to COPD RS ( p < 0.05) and reduced IL‐10 and TGFß1 in COPD S as compared to CNS ( p < 0.05) and CS ( p < 0.05) was observed in the culture supernatants of suppression assay. In addition, a significantly higher frequency of iTregs with phenotype CD4+CD25+CD45RA+CD127− was observed in COPD S as compared to COPD RS ( p < 0.01). Discussion: Characteristics changes were observed in patients with COPD. The compromised Tregs function, despite the increase in systemic inflammation, suggests a potential role of these cells in the pathogenesis of the disease.
- 14 September 2024
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 64 (suppl 68) , PA644
Phenotypic characterization of Natural Killer Cells in Post Tuberculosis Pulmonary Sequelae
Rationale: Natural killer (NK) cells, key effector cells of the innate immune system, play an important role in the clearance and control of Mycobacterium tuberculosis. These cells produce high levels of proinflammatory cytokines in response to pathogens and have the capability to induce apoptosis in target cells via the release of perforin and granzymes. In view of the remarkable cytotoxic activity of NK cells, the aim of this study is to phenotypically characterise circulating NK cells in patients diagnosed with post tuberculosis sequelae. Methods: Patients having chronic anatomic and symptomatic sequelae arising from previously treated and microbiologically cured pulmonary tuberculosis (TB) (PTS, n=9), patients who recovered from pulmonary TB without having any anatomic or symptomatic sequelae (PTWS, n=10) and healthy participants (C, n=15) were recruited in this study. Flow Cytometry was performed on peripheral blood mononuclear cells to identify circulatory NK cells with phenotype CD3-CD56+Granzyme+/Perforin+. Results: The percentage of NK cells (CD3-CD56+) was significantly lower in post TB with sequelae patients as compared to healthy controls (53.75±15.25 Vs 82.58±18.04, p= 0.007). Percentage of NK cells expressing granzyme was higher in post TB with sequelae patients as compared to post TB without sequelae patients [28.75 (21.48-35.08) Vs. 4.35 (2.67-17.6), p=0.006] while percentage of NK cells expressing perforin was comparable between all the groups. Conclusion: Post Tuberculosis pulmonary sequelae is associated with decreased number of NK cells but increased expression of granzyme in these cells.
- 14 September 2024
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 64 (suppl 68) , PA644
Phenotypic characterization of Natural Killer Cells in Post Tuberculosis Pulmonary Sequelae
Rationale: Natural killer (NK) cells, key effector cells of the innate immune system, play an important role in the clearance and control of Mycobacterium tuberculosis. These cells produce high levels of proinflammatory cytokines in response to pathogens and have the capability to induce apoptosis in target cells via the release of perforin and granzymes. In view of the remarkable cytotoxic activity of NK cells, the aim of this study is to phenotypically characterise circulating NK cells in patients diagnosed with post tuberculosis sequelae. Methods: Patients having chronic anatomic and symptomatic sequelae arising from previously treated and microbiologically cured pulmonary tuberculosis (TB) (PTS, n=9), patients who recovered from pulmonary TB without having any anatomic or symptomatic sequelae (PTWS, n=10) and healthy participants (C, n=15) were recruited in this study. Flow Cytometry was performed on peripheral blood mononuclear cells to identify circulatory NK cells with phenotype CD3-CD56+Granzyme+/Perforin+. Results: The percentage of NK cells (CD3-CD56+) was significantly lower in post TB with sequelae patients as compared to healthy controls (53.75±15.25 Vs 82.58±18.04, p= 0.007). Percentage of NK cells expressing granzyme was higher in post TB with sequelae patients as compared to post TB without sequelae patients [28.75 (21.48-35.08) Vs. 4.35 (2.67-17.6), p=0.006] while percentage of NK cells expressing perforin was comparable between all the groups. Conclusion: Post Tuberculosis pulmonary sequelae is associated with decreased number of NK cells but increased expression of granzyme in these cells.
- 9 September 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 62 (suppl 67) , PA615
Functional characterization of FoxP3+ regulatory T cells in Chronic Obstructive Pulmonary Disease
Background: COPD is associated with chronic pulmonary and systemic inflammation. An imbalance between proinflammatory and antiinflammatory factors plays an important role in disease progression. T-Regulatory cells (Tregs) being the negative regulator of immune response have gained attention in many inflammatory diseases However, the functional role of Tregs in COPD is not clearly defined. Aim: To evaluate the relative percentage and suppressive functions of circulating T regulatory cells in COPD and controls Methodology: The study was conducted in 14 COPD patients (smokers n=7, reformed smokers n=7) and 14 age-matched healthy controls (smokers n=7, non-smokers n=7). PBMC were isolated and circulatory Tregs with phenotype CD4+CD25+CD45RA-CD127-FoxP3+ were identified by Flow Cytometry. The suppressive function of Tregs was evaluated by assessing the proliferation of T responder cells (CD4+CD25-) in the presence of circulatory Tregs (CD4+CD25+) under polyclonal stimulation. Results: FoxP3+ Tregs as a percentage of CD4+CD25+CD45RA-CD127-FoxP3+ were lower in COPD smokers as compared to control smokers ((60.1(66.7-56.4) vs. (90.4(91.9-78.4) p=0.04) and non-smokers ((60.1(66.7-56.4) vs. (95.5(96.7-89.8) p=0.0006). The percent suppression of T responder cells by Tregs was also lower in COPD smokers ((31.2(40.5-20.3) vs(63.4(82.8-53.0) p=0.03) and COPD reformed smokers ((25.65(37.7-24.2) vs. (63.4(82.8-53.0) p=0.04) as compared to control smokers. Conclusion: COPD is associated with a lower percentage and reduced suppressive capacity of T regulatory cells in peripheral circulation which may suggest their inability to suppress the persistent inflammatory response in COPD.
- 9 September 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 62 (suppl 67) , PA615
Functional characterization of FoxP3+ regulatory T cells in Chronic Obstructive Pulmonary Disease
Background: COPD is associated with chronic pulmonary and systemic inflammation. An imbalance between proinflammatory and antiinflammatory factors plays an important role in disease progression. T-Regulatory cells (Tregs) being the negative regulator of immune response have gained attention in many inflammatory diseases However, the functional role of Tregs in COPD is not clearly defined. Aim: To evaluate the relative percentage and suppressive functions of circulating T regulatory cells in COPD and controls Methodology: The study was conducted in 14 COPD patients (smokers n=7, reformed smokers n=7) and 14 age-matched healthy controls (smokers n=7, non-smokers n=7). PBMC were isolated and circulatory Tregs with phenotype CD4+CD25+CD45RA-CD127-FoxP3+ were identified by Flow Cytometry. The suppressive function of Tregs was evaluated by assessing the proliferation of T responder cells (CD4+CD25-) in the presence of circulatory Tregs (CD4+CD25+) under polyclonal stimulation. Results: FoxP3+ Tregs as a percentage of CD4+CD25+CD45RA-CD127-FoxP3+ were lower in COPD smokers as compared to control smokers ((60.1(66.7-56.4) vs. (90.4(91.9-78.4) p=0.04) and non-smokers ((60.1(66.7-56.4) vs. (95.5(96.7-89.8) p=0.0006). The percent suppression of T responder cells by Tregs was also lower in COPD smokers ((31.2(40.5-20.3) vs(63.4(82.8-53.0) p=0.03) and COPD reformed smokers ((25.65(37.7-24.2) vs. (63.4(82.8-53.0) p=0.04) as compared to control smokers. Conclusion: COPD is associated with a lower percentage and reduced suppressive capacity of T regulatory cells in peripheral circulation which may suggest their inability to suppress the persistent inflammatory response in COPD.
- Open Access
- 1 August 2023
- Published by MDPI AG in Biomedicines
- Vol. 11 (8) , 2166
Phenotypic Profiling of Immune Cells and Their Mediators in Chronic Obstructive Pulmonary Disease
Background: Chronic obstructive pulmonary disease (COPD) is an inflammatory disorder and has been proposed to have an imbalance between pro-inflammatory and anti-inflammatory factors. Methods: This study was conducted on 41 participants {18 COPD patients (smokers, COPD S (n = 9); reformed smokers, COPD RS (n = 9)) and 23 controls (non-smokers, CNS (n = 14); smokers, CS (n = 9))}. Flow cytometry was used to identify circulatory immune cells and correlated with serum cytokines. Results: On comparison, significantly lower frequency of CD3+ T cells were observed in COPD S as compared to CNS (p < 0.01) and CS (p < 0.01); CD4+ T cells were lower in COPD S (p < 0.05), COPD RS (p < 0.05) and CNS (p < 0.01) as compared to CS. CD8+ T cells were elevated in COPD S as compared to CS (p < 0.05). Lower frequency of cDCs were observed in COPD S as compared to CS (p < 0.05) and COPD RS as compared to CNS (p < 0.01) and CS (p < 0.01). Lower frequency of pDCs were observed in COPD RS as compared to COPD S (p < 0.05), CNS (p < 0.05) and CS (p < 0.01). Lower frequency of Tregs was observed in COPD S as compared to CNS (p < 0.05) and CS (p < 0.05). Conclusions: Characteristic changes observed indicate a significant impact of immune cells in the progression of the disease.
- 1 August 2023
- Published by MDPI AG in Biomedicines
- Vol. 11 (8) , 2166
Open AccessPhenotypic Profiling of Immune Cells and Their Mediators in Chronic Obstructive Pulmonary Disease
Background: Chronic obstructive pulmonary disease (COPD) is an inflammatory disorder and has been proposed to have an imbalance between pro-inflammatory and anti-inflammatory factors. Methods: This study was conducted on 41 participants {18 COPD patients (smokers, COPD S (n = 9); reformed smokers, COPD RS (n = 9)) and 23 controls (non-smokers, CNS (n = 14); smokers, CS (n = 9))}. Flow cytometry was used to identify circulatory immune cells and correlated with serum cytokines. Results: On comparison, significantly lower frequency of CD3+ T cells were observed in COPD S as compared to CNS (p < 0.01) and CS (p < 0.01); CD4+ T cells were lower in COPD S (p < 0.05), COPD RS (p < 0.05) and CNS (p < 0.01) as compared to CS. CD8+ T cells were elevated in COPD S as compared to CS (p < 0.05). Lower frequency of cDCs were observed in COPD S as compared to CS (p < 0.05) and COPD RS as compared to CNS (p < 0.01) and CS (p < 0.01). Lower frequency of pDCs were observed in COPD RS as compared to COPD S (p < 0.05), CNS (p < 0.05) and CS (p < 0.01). Lower frequency of Tregs was observed in COPD S as compared to CNS (p < 0.05) and CS (p < 0.05). Conclusions: Characteristic changes observed indicate a significant impact of immune cells in the progression of the disease.
- Open Access
- 6 April 2022
- Published by Wolters Kluwer Health in Annals of Indian Academy of Neurology
- Vol. 25 (4) , 683-687
Respiratory Dysfunction in Parkinson's Disease
Background: Parkinson's disease (PD) is a neurodegenerative disease perceived as a motor disorder. It is most commonly associated with autonomic dysfunction, affecting multiple systems. This altered autonomic control might be reflected by a parallel change in the airway caliber of these patients. Aim: To correlate the pulmonary impairment in patients with Parkinson's disease with the underlying dysautonomia. Materials and Methods: A total of 30 patients with Parkinson's disease participated in the study. Heart rate (HR) variability was recorded for 5 min to assess the autonomic dysfunction, followed by impulse oscillometry (IOS) and spirometry. IOS being an effort independent technique uses sound waves at different frequencies (5–25 Hz) to measure the airway impedance. Results: There was a significant decrease in SDSD (6.60 (10.18–6.01) vs. 12.22 (13.95–11.30); P = 0.04), RMSSD (6.59 (10.17–5.50) vs. 12.20 (13.93–11.28); P = 0.04), and total power (315.8 (506.3–120.7) vs. 771.3 (799.0–643.6); P = 0.04) in stage II as compared to stage I. Resistance at 20 Hz (R20) was found to be positively correlated with SDSD (r = 0.40, P = 0.04), RMSSD (r = 0.40, P = 0.04), and HF (r = 0.41, P = 0.03). Conclusion: Amongst the PD population, any changes in the parasympathetic component (responsible for bronchoconstriction) due to the underlying dysautonomia might be reflected as increased airway resistance in the pulmonary system.
- 6 April 2022
- Published by Wolters Kluwer Health in Annals of Indian Academy of Neurology
- Vol. 25 (4) , 683-687
Open AccessRespiratory Dysfunction in Parkinson's Disease
Background: Parkinson's disease (PD) is a neurodegenerative disease perceived as a motor disorder. It is most commonly associated with autonomic dysfunction, affecting multiple systems. This altered autonomic control might be reflected by a parallel change in the airway caliber of these patients. Aim: To correlate the pulmonary impairment in patients with Parkinson's disease with the underlying dysautonomia. Materials and Methods: A total of 30 patients with Parkinson's disease participated in the study. Heart rate (HR) variability was recorded for 5 min to assess the autonomic dysfunction, followed by impulse oscillometry (IOS) and spirometry. IOS being an effort independent technique uses sound waves at different frequencies (5–25 Hz) to measure the airway impedance. Results: There was a significant decrease in SDSD (6.60 (10.18–6.01) vs. 12.22 (13.95–11.30); P = 0.04), RMSSD (6.59 (10.17–5.50) vs. 12.20 (13.93–11.28); P = 0.04), and total power (315.8 (506.3–120.7) vs. 771.3 (799.0–643.6); P = 0.04) in stage II as compared to stage I. Resistance at 20 Hz (R20) was found to be positively correlated with SDSD (r = 0.40, P = 0.04), RMSSD (r = 0.40, P = 0.04), and HF (r = 0.41, P = 0.03). Conclusion: Amongst the PD population, any changes in the parasympathetic component (responsible for bronchoconstriction) due to the underlying dysautonomia might be reflected as increased airway resistance in the pulmonary system.
- Open Access
- 1 January 2022
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 17, 65-77
Effect of Smoking and Its Cessation on the Transcript Profile of Peripheral Monocytes in COPD Patients
Dove Press is a member of the Open Access Initiative, specializing in peer reviewed Medical Journals. View articlesor submit your research for publishing
- 1 January 2022
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 17, 65-77
Open AccessEffect of Smoking and Its Cessation on the Transcript Profile of Peripheral Monocytes in COPD Patients
Dove Press is a member of the Open Access Initiative, specializing in peer reviewed Medical Journals. View articlesor submit your research for publishing
- Open Access
- 8 January 2021
- Published by MDPI AG in Biomedicines
- Vol. 9 (1) , 53
Orchestration of Neutrophil Extracellular Traps (Nets), a Unique Innate Immune Function during Chronic Obstructive Pulmonary Disease (COPD) Development
Morbidity, mortality and economic burden caused by chronic obstructive pulmonary disease (COPD) is a significant global concern. Surprisingly, COPD is already the third leading cause of death worldwide, something that WHO had not predicted to occur until 2030. It is characterized by persistent respiratory symptoms and airway limitation due to airway and/or alveolar abnormalities usually caused by significant exposure to noxious particles of gases. Neutrophil is one of the key infiltrated innate immune cells in the lung during the pathogenesis of COPD. Neutrophils during pathogenic attack or injury decide to undergo for a suicidal death by releasing decondensed chromatin entangled with antimicrobial peptides to trap and ensnare pathogens. Casting neutrophil extracellular traps (NETs) has been widely demonstrated to be an effective mechanism against invading microorganisms thus controlling overwhelming infections. However, aberrant and massive NETs formation has been reported in several pulmonary diseases, including chronic obstructive pulmonary disease. Moreover, NETs can directly induce epithelial and endothelial cell death resulting in impairing pulmonary function and accelerating the progression of the disease. Therefore, understanding the regulatory mechanism of NET formation is the need of the hour in order to use NETs for beneficial purpose and controlling their involvement in disease exacerbation. For example, DNA neutralization of NET proteins using protease inhibitors and disintegration with recombinant human DNase would be helpful in controlling excess NETs. Targeting CXC chemokine receptor 2 (CXCR2) would also reduce neutrophilic inflammation, mucus production and neutrophil-proteinase mediated tissue destruction in lung. In this review, we discuss the interplay of NETs in the development and pathophysiology of COPD and how these NETs associated therapies could be leveraged to disrupt NETopathic inflammation as observed in COPD, for better management of the disease.
- 8 January 2021
- Published by MDPI AG in Biomedicines
- Vol. 9 (1) , 53
Open AccessOrchestration of Neutrophil Extracellular Traps (Nets), a Unique Innate Immune Function during Chronic Obstructive Pulmonary Disease (COPD) Development
Morbidity, mortality and economic burden caused by chronic obstructive pulmonary disease (COPD) is a significant global concern. Surprisingly, COPD is already the third leading cause of death worldwide, something that WHO had not predicted to occur until 2030. It is characterized by persistent respiratory symptoms and airway limitation due to airway and/or alveolar abnormalities usually caused by significant exposure to noxious particles of gases. Neutrophil is one of the key infiltrated innate immune cells in the lung during the pathogenesis of COPD. Neutrophils during pathogenic attack or injury decide to undergo for a suicidal death by releasing decondensed chromatin entangled with antimicrobial peptides to trap and ensnare pathogens. Casting neutrophil extracellular traps (NETs) has been widely demonstrated to be an effective mechanism against invading microorganisms thus controlling overwhelming infections. However, aberrant and massive NETs formation has been reported in several pulmonary diseases, including chronic obstructive pulmonary disease. Moreover, NETs can directly induce epithelial and endothelial cell death resulting in impairing pulmonary function and accelerating the progression of the disease. Therefore, understanding the regulatory mechanism of NET formation is the need of the hour in order to use NETs for beneficial purpose and controlling their involvement in disease exacerbation. For example, DNA neutralization of NET proteins using protease inhibitors and disintegration with recombinant human DNase would be helpful in controlling excess NETs. Targeting CXC chemokine receptor 2 (CXCR2) would also reduce neutrophilic inflammation, mucus production and neutrophil-proteinase mediated tissue destruction in lung. In this review, we discuss the interplay of NETs in the development and pathophysiology of COPD and how these NETs associated therapies could be leveraged to disrupt NETopathic inflammation as observed in COPD, for better management of the disease.
- Open Access
- 1 January 2021
- Vol. 38 (3)
IMPULSE OSCILLOMETRY AS A MEASURE OF AIRWAY DYSFUNCTION IN SARCOIDOSIS
Background: Sarcoidosis is a systemic inflammatory granulomatous disease which commonly affects intrathoracic lymph nodes, lung parenchyma and airways. Objectives: To measure respiratory impedance using Impulse Oscillometry (IOS) in patients with pulmonary sarcoidosis and compare the parameters with healthy controls. Methods: Patients diagnosed with sarcoidosis (n=28); and age and gender matched healthy controls (n=17) were recruited. Lung volumes and capacities were measured by spirometry and respiratory system impedance was assessed using Impulse Oscillometry System (IOS). Measurements were performed before and 15 minutes after inhalation of a short acting bronchodilator. The IOS and spirometric parameters were compared between two groups and correlated. ROC curve analysis was also performed to identify the IOS parameters which can discriminate between sarcoidosis and healthy controls. Results: Resistance at 5 and 20 Hz (R5 and R20), small airway resistance (R5-R20), resonant frequency (F-Res) and area of reactance (AX) were significantly higher in Sarcoidosis subjects compared with controls. Reactance at 5 and 20 Hz (X5 and X20) were significantly lower in sarcoidosis. FEV1 (% predicted) and FVC (% predicted) were significantly lower in patients with sarcoidosis while FEV1/FVC ratio and peak expiratory flow rate (PEF) values were comparable. Post bronchodilator inhalation, there was improvement in airway resistance and reactance, but no significant changes observed in spirometric parameters. R5, X5 and R5-R20 are promising parameters to discriminate sarcoidosis from healthy controls. Conclusion: Increased airway resistance is a better indicator of airway involvement than airflow limitation by spirometry in pulmonary sarcoidosis.
- 1 January 2021
- Vol. 38 (3)
Open AccessIMPULSE OSCILLOMETRY AS A MEASURE OF AIRWAY DYSFUNCTION IN SARCOIDOSIS
Background: Sarcoidosis is a systemic inflammatory granulomatous disease which commonly affects intrathoracic lymph nodes, lung parenchyma and airways. Objectives: To measure respiratory impedance using Impulse Oscillometry (IOS) in patients with pulmonary sarcoidosis and compare the parameters with healthy controls. Methods: Patients diagnosed with sarcoidosis (n=28); and age and gender matched healthy controls (n=17) were recruited. Lung volumes and capacities were measured by spirometry and respiratory system impedance was assessed using Impulse Oscillometry System (IOS). Measurements were performed before and 15 minutes after inhalation of a short acting bronchodilator. The IOS and spirometric parameters were compared between two groups and correlated. ROC curve analysis was also performed to identify the IOS parameters which can discriminate between sarcoidosis and healthy controls. Results: Resistance at 5 and 20 Hz (R5 and R20), small airway resistance (R5-R20), resonant frequency (F-Res) and area of reactance (AX) were significantly higher in Sarcoidosis subjects compared with controls. Reactance at 5 and 20 Hz (X5 and X20) were significantly lower in sarcoidosis. FEV1 (% predicted) and FVC (% predicted) were significantly lower in patients with sarcoidosis while FEV1/FVC ratio and peak expiratory flow rate (PEF) values were comparable. Post bronchodilator inhalation, there was improvement in airway resistance and reactance, but no significant changes observed in spirometric parameters. R5, X5 and R5-R20 are promising parameters to discriminate sarcoidosis from healthy controls. Conclusion: Increased airway resistance is a better indicator of airway involvement than airflow limitation by spirometry in pulmonary sarcoidosis.